Company: OMQS
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001813
Chunk: 502

Company: OMNIQ Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 7
Chunk 502
---
 December 2021, shareholders’ meeting. On February 25, 2022, the Company granted 792,500
stock options. These options were granted to employees as part of the Plan. On October 23, 2022 19,000 stock options were granted to
employees as part of the Plan. No shares were issued under the Plan in 2023.

In
December 2015, our Board of Directors approved the OMNIQ’s Employee Stock Purchase Plan (the “ESPP”). For the years
ending December 31, 2023 and 2022, employees purchased 14,838 ($31 thousand) shares and 7,025 ($37 thousand) shares of commons stock.

On
October 5, 2023, OmniQ Corp. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”)
with ThinkEquity LLC, as representatives (the “Representatives”) of the several underwriters named therein (collectively,
the “Underwriters”), relating to the issuance and sale (the “Offering”) of 2,775,000 shares of the Company’s
common stock, par value $0.001 per share, at a price to the public of $1.00 per share (the “Underwritten Shares”) and pre-funded
warrants (the “Pre-Funded Warrants”) to purchase 225,000 shares of the Company’s common stock at a price to the public
of $0.999 per Pre-Funded Warrant. Under the terms of the Underwriting Agreement, the Underwriters have agreed to purchase the Underwritten
Shares from the Company at a price of $1.00 per share and the Pre-Funded Warrants at a price of $0.999 per Pre-Funded Warrant. The Company
also granted the Underwriters an option exercisable for 45 days from the date of the Underwriting Agreement to purchase up to an additional
450,000 shares of common stock solely for the purpose of covering over-allotments (together with the Underwritten Shares, the “Shares”).
All of the Shares and Pre-Funded Warrants in the Offering are being sold by the Company. The Company also issued warrants to the Representative
(the “Representative’s Warrants”), exercisable to purchase 140,000 shares of common stock, at an exercise price of
$1.25 per share.

    F-21

The
gross proceeds from the Offering were approximately $3.